The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission (FTC) released its second interim staff report on prescription drug middlemen.

The AI race heats up with a new kid on the block from China. How did it compare against a popular U.S. genAI engine on a simple healthcare industry question?

Healthcare providers and vendors are learning the hard way that hackers are relentless and resourceful, constantly adjusting ...

The vast majority of healthcare organizations have spotted a cyberattack and suffered financial consequences as a result in the past 12 months, according to new research. A separate report also found ...

Radiotherapy was a key focus among attendees. Radiotherapy, also known as radiation therapy, uses targeted radiation to kill cancer cells and shrink tumors. The radiotherapy market is growing ...

A next-generation Novo Nordisk obesity drug designed to hit two targets has preliminary clinical data showing 22% weight loss, results that suggest the once-weekly injection could have an edge ...

ICHRA — Individual Coverage Health Reimbursement Arrangement — seems to be the new buzzword of 2025. The interest in ICHRA stems from dissatisfaction with traditional group health insurance.

This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive appointment ...

Virtual women’s health company Allara Health has raised $26 million in Series B funding, which it will use to further support women battling chronic hormonal conditions, the company announced on ...

Look at recent big pharma asset acquisitions and new biotech company launches, and you might spot a common theme: The drugs at the heart of these deals were originally developed in China.

Our nation has been experiencing a mental health crisis for several years, marked by an alarming rise in mental illness that shows no signs of slowing down. 23% of adults experienced a mental ...